MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
338.80%
Quick Ratio
338.80%
Cash Ratio
106.52%
Debt to Asset Ratio
25.03%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Deferred tax assets
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
384,985
282,212
177,695
257,996
Investment securities, available-for-sale
571,489
569,246
641,991
589,023
Accounts receivable, net
150,642
135,350
121,457
115,850
Interest and other receivables
15,688
13,034
26,774
23,588
Inventory
32,372
31,574
34,670
29,097
Prepaid expenses
-
64,600
59,526
60,868
Prepaid expenses and other current assets
69,369
-
-
-
Total current assets
1,224,545
1,096,016
1,062,113
1,076,422
Property and equipment, gross
-
-
16,995
-
Accumulated depreciation
-
-
9,484
-
Property and equipment, net
17,107
14,652
7,511
3,708
Operating lease right-of-use assets
69,424
46,274
47,354
49,673
Intangible assets, net
103,448
106,171
108,893
111,615
Restricted cash
7,846
7,846
7,845
9,471
Long-term inventory
76,301
80,719
76,704
76,888
Deferred tax assets
240,679
249,624
249,879
-
Other assets
3,550
3,928
3,896
2,994
Total assets
1,742,900
1,605,230
1,564,195
1,330,771
Accounts payable
44,566
12,246
10,903
21,747
Accrued liabilities
316,870
293,278
266,211
334,837
Total current liabilities
361,436
305,524
277,114
356,584
Operating lease liabilities
59,547
39,003
40,554
43,026
Other long-term liabilities
15,308
12,637
19,137
13,889
Total liabilities
436,291
357,164
336,805
413,499
Common stock, 0.0001 par value 225,000,000 shares authorized at june 30, 2026 and december 31, 2025 172,132,442 shares and 170,309,376 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
16
16
16
16
Additional paid-in capital
3,085,800
3,058,362
3,039,315
3,003,221
Accumulated deficit
-1,778,249
-1,809,749
-1,813,386
-2,086,954
Accumulated other comprehensive (loss) income
-958
-563
1,445
989
Total stockholders equity
1,306,609
1,248,066
1,227,390
917,272
Total liabilities and stockholders equity
1,742,900
1,605,230
1,564,195
1,330,771
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Investment securities,available-for-sale$571,489K (12.42%↑ Y/Y)Cash and cashequivalents$384,985K (51.79%↑ Y/Y)Accounts receivable, net$150,642K (40.13%↑ Y/Y)Prepaid expenses andother current assets$69,369K Inventory$32,372K (23.92%↑ Y/Y)Interest and otherreceivables$15,688K (28.79%↑ Y/Y)Total current assets$1,224,545K (27.48%↑ Y/Y)Deferred tax assets$240,679K Intangible assets, net$103,448K (-9.52%↓ Y/Y)Long-term inventory$76,301K (-9.60%↓ Y/Y)Operating leaseright-of-use assets$69,424K (36.15%↑ Y/Y)Property and equipment,net$17,107K (382.29%↑ Y/Y)Restricted cash$7,846K (-17.16%↓ Y/Y)Other assets$3,550K (57.57%↑ Y/Y)Total assets$1,742,900K (42.21%↑ Y/Y)Total liabilities andstockholders equity$1,742,900K (42.21%↑ Y/Y)Total stockholdersequity$1,306,609K (58.88%↑ Y/Y)Total liabilities$436,291K (8.21%↑ Y/Y)Accumulated deficit-$1,778,249K (17.63%↑ Y/Y)Accumulated othercomprehensive (loss) income-$958K (-335.96%↓ Y/Y)Additional paid-in capital$3,085,800K (3.53%↑ Y/Y)Total currentliabilities$361,436K (9.52%↑ Y/Y)Operating leaseliabilities$59,547K (33.51%↑ Y/Y)Other long-termliabilities$15,308K (-46.38%↓ Y/Y)Common stock, 0.0001par value...$16K (0.00%↑ Y/Y)Accrued liabilities$316,870K (2.24%↑ Y/Y)Accounts payable$44,566K (121.75%↑ Y/Y)

ACADIA PHARMACEUTICALS INC (ACAD)

ACADIA PHARMACEUTICALS INC (ACAD)